Meropenem Hikma (Meropenem Anhydrous)

Meropenem Hikma is a broad‑spectrum carbapenem antibiotic used to treat severe infections caused by susceptible bacteria.

• Complicated intra‑abdominal infections: provides bacterial eradication in polymicrobial abdominal sepsis.
• Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis.
• Skin and soft tissue infections: resolves deep tissue infections with gram‑negative and anaerobic organisms.
• Community‑acquired and hospital‑acquired pneumonia: treats resistant respiratory pathogens.
• Meningitis: penetrates the cerebrospinal fluid to combat bacterial meningitis.

• Meropenem binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption leads to weakened cell walls, osmotic instability, and ultimately bacterial lysis. Its structure confers resistance to most β‑lactamases, providing activity against a wide range of gram‑positive, gram‑negative, and anaerobic organisms.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: may be watery and self‑limiting.
• Headache: transient and usually resolves.
• Infusion site reactions: redness or discomfort at the injection site.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or CNS disorders.
• Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome.
• Clostridioides difficile‑associated diarrhea: can be life‑threatening.
• Hematologic abnormalities: neutropenia, thrombocytopenia, or anemia.
• Renal impairment: worsening kidney function in susceptible individuals.
• Hepatotoxicity: elevated liver enzymes or jaundice.

Before using Meropenem Hikma, consider the following precautions:

• Renal function: adjust dose in patients with impaired renal clearance.
• Seizure risk: monitor patients with a history of seizures or CNS disorders.
• Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams.
• Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze, and retain in the original packaging.

Meropenem Hikma may interact with other medicines as follows:

Major Interactions (Avoid)

• Valproic acid: increased risk of seizures.
• Probenecid: may raise meropenem plasma concentrations.
• Cytotoxic agents: potential additive nephrotoxicity.

Moderate Interactions (Monitor Closely)

• Loop diuretics: monitor renal function and electrolytes.
• Aminoglycosides: watch for combined nephrotoxic effects.
• Anticoagulants (e.g., warfarin): observe coagulation parameters for possible alterations.